These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28223022)

  • 1. Early identification of mild cognitive impairment using incomplete random forest-robust support vector machine and FDG-PET imaging.
    Lu S; Xia Y; Cai W; Fulham M; Feng DD;
    Comput Med Imaging Graph; 2017 Sep; 60():35-41. PubMed ID: 28223022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early identification of MCI converting to AD: a FDG PET study.
    Pagani M; Nobili F; Morbelli S; Arnaldi D; Giuliani A; Öberg J; Girtler N; Brugnolo A; Picco A; Bauckneht M; Piva R; Chincarini A; Sambuceti G; Jonsson C; De Carli F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2042-2052. PubMed ID: 28664464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares.
    Wang P; Chen K; Yao L; Hu B; Wu X; Zhang J; Ye Q; Guo X;
    J Alzheimers Dis; 2016 Aug; 54(1):359-71. PubMed ID: 27567818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images.
    Shen T; Jiang J; Lu J; Wang M; Zuo C; Yu Z; Yan Z
    Mol Imaging; 2019; 18():1536012119877285. PubMed ID: 31552787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
    Choi H; Jin KH;
    Behav Brain Res; 2018 May; 344():103-109. PubMed ID: 29454006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
    Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
    J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
    Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of FDG-PET for the clinical diagnosis in MCI.
    Arbizu J; Festari C; Altomare D; Walker Z; Bouwman F; Rivolta J; Orini S; Barthel H; Agosta F; Drzezga A; Nestor P; Boccardi M; Frisoni GB; Nobili F;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1497-1508. PubMed ID: 29704037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Alzheimer's disease and mild cognitive impairment using multimodal sparse hierarchical extreme learning machine.
    Kim J; Lee B
    Hum Brain Mapp; 2018 Sep; 39(9):3728-3741. PubMed ID: 29736986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment.
    Li Q; Wu X; Xu L; Chen K; Yao L; Li R
    Comput Methods Programs Biomed; 2017 Oct; 150():1-8. PubMed ID: 28859825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilevel Feature Representation of FDG-PET Brain Images for Diagnosing Alzheimer's Disease.
    Pan X; Adel M; Fossati C; Gaidon T; Guedj E
    IEEE J Biomed Health Inform; 2019 Jul; 23(4):1499-1506. PubMed ID: 30028716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA
    Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression.
    Teipel SJ; Kurth J; Krause B; Grothe MJ;
    Neuroimage Clin; 2015; 8():583-93. PubMed ID: 26199870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.